Search

Your search keyword '"Spencer, Christine"' showing total 455 results

Search Constraints

Start Over You searched for: Author "Spencer, Christine" Remove constraint Author: "Spencer, Christine"
455 results on '"Spencer, Christine"'

Search Results

103. Abstract CT156: Novel neoadjuvant targeted therapy trial yields insight into molecular mechanisms of response

104. Abstract 2672: Response to anti-PD-1 based therapy in metastatic melanoma patients is associated with the diversity and composition of the gut microbiome

105. Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study

106. Multidimensional spatial characterization of the tumor microenvironment (TME) in synchronous melanoma metastases (SMM) to yield insights into mixed responses to therapy in metastatic melanoma (MM) patients (pts).

107. Association of the diversity and composition of the gut microbiome with responses and survival (PFS) in metastatic melanoma (MM) patients (pts) on anti-PD-1 therapy.

108. Molecular and immune predictors of response and toxicity to combined CTLA-4 and PD-1 blockade in metastatic melanoma (MM) patients (pts).

109. Association of diversity and composition of the gut microbiome with differential responses to PD-1 based therapy in patients with metastatic melanoma.

111. It Is a Capital Mistake to Theorize Who to Treat with Checkpoint Inhibitors before One Has Data

112. Perfluoroalkylphosphinic Acids in Northern Pike (Esox lucius), Double-Crested Cormorants (Phalacrocorax auritus), and Bottlenose Dolphins (Tursiops truncatus) in Relation to Other Perfluoroalkyl Acids

113. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

114. Abstract 2392: Genomic and immune heterogeneity in synchronous melanoma metastases is associated with differential tumor growth and response to therapy

115. The impact of obesity on outcomes in metastatic melanoma (MM) patients (pts) treated with dabrafenib and trametinib.

116. Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma

118. Molecular and immune heterogeneity in synchronous melanoma metastases

119. Pilot study of intratumoral (IT) cryoablation (cryo) in combination with systemic checkpoint blockade in patients with metastatic melanoma (MM)

121. Continuous Non-Marine Inputs of Per- and Polyfluoroalkyl Substances to the High Arctic: A Multi-Decadal Temporal Record.

122. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.

124. Measurement and analysis of intraservice work

125. Perfluoroalkyl Acids in the Atlantic and Canadian Arctic Oceans

126. Manufacturing Origin of Perfluorooctanoate (PFOA) in Atlantic and Canadian Arctic Seawater

127. Manufacturing origin of perfluorooctanoate (PFOA) in Atlantic and Canadian Arctic seawater

131. Perfluoroalkyl Acids in the Atlantic and Canadian Arctic Oceans

Catalog

Books, media, physical & digital resources